We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Docking Studies and Ligand Recognition for Allosteric Modifiers of Hemoglobin
Poster

Docking Studies and Ligand Recognition for Allosteric Modifiers of Hemoglobin

Docking Studies and Ligand Recognition for Allosteric Modifiers of Hemoglobin
Poster

Docking Studies and Ligand Recognition for Allosteric Modifiers of Hemoglobin

Abstract

Oxygen binding affinity of hemoglobin can be modulated by various natural and synthetic allosteric effectors. There is considerable interest in designing agents that produce low-affinity Hbs. Such agents have several potential clinical applications. The aim of this study is to show how a molecular docking strategy can be successfully used to investigate the inhibition mechanism of these synthetic compounds.
Advertisement